The estimated Net Worth of Michael Sofinnova Venture P... is at least 37.9 百万$ dollars as of 11 August 2020. Michael P owns over 133,333 units of Checkmate Pharmaceuticals stock worth over 37,870,424$ and over the last 4 years Michael sold CMPI stock worth over 0$.
Michael has made over 1 trades of the Checkmate Pharmaceuticals stock since 2020, according to the Form 4 filled with the SEC. Most recently Michael bought 133,333 units of CMPI stock worth 1,999,995$ on 11 August 2020.
The largest trade Michael's ever made was buying 133,333 units of Checkmate Pharmaceuticals stock on 11 August 2020 worth over 1,999,995$. On average, Michael trades about 133,333 units every 0 days since 2020. As of 11 August 2020 Michael still owns at least 3,606,707 units of Checkmate Pharmaceuticals stock.
You can see the complete history of Michael P stock trades at the bottom of the page.
Over the last 4 years, insiders at Checkmate Pharmaceuticals have traded over 15,801,789$ worth of Checkmate Pharmaceuticals stock and bought 928,470 units worth 13,457,615$ . The most active insiders traders include Holdings A/S Novo、Global Strategic Fund Ii L....、Michael Powell. On average, Checkmate Pharmaceuticals executives and independent directors trade stock every 27 days with the average trade being worth of 1,077,132$. The most recent stock trade was executed by Global Strategic Fund Ii L.... on 13 May 2022, trading 131,650 units of CMPI stock currently worth 1,375,743$.
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Checkmate Pharmaceuticals executives and other stock owners filed with the SEC include: